This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2007 Nov;35(8):689-90.

doi: 10.1111/j.1442-9071.2007.01616.x.

Are we getting closer to prevention and treatment of corneal neovascularization?

Patricia Chévez-Barrios

PMID: 17997767
DOI: 10.1111/j.1442-9071.2007.01616.x

Editorial

Are we getting closer to prevention and treatment of corneal neovascularization?

Patricia Chévez-Barrios. Clin Exp Ophthalmol. 2007 Nov.

. 2007 Nov;35(8):689-90.

doi: 10.1111/j.1442-9071.2007.01616.x.

Author

Patricia Chévez-Barrios

PMID: 17997767
DOI: 10.1111/j.1442-9071.2007.01616.x

No abstract available

PubMed Disclaimer

Comment on

Bevacizumab inhibits corneal neovascularization in an alkali burn induced model of corneal angiogenesis.
Hosseini H, Nejabat M, Mehryar M, Yazdchi T, Sedaghat A, Noori F. Hosseini H, et al. Clin Exp Ophthalmol. 2007 Nov;35(8):745-8. doi: 10.1111/j.1442-9071.2007.01572.x. Clin Exp Ophthalmol. 2007. PMID: 17997779

Similar articles

Bevacizumab inhibits corneal neovascularization in an alkali burn induced model of corneal angiogenesis.
Hosseini H, Nejabat M, Mehryar M, Yazdchi T, Sedaghat A, Noori F. Hosseini H, et al. Clin Exp Ophthalmol. 2007 Nov;35(8):745-8. doi: 10.1111/j.1442-9071.2007.01572.x. Clin Exp Ophthalmol. 2007. PMID: 17997779
Topical bevacizumab therapy for corneal neovascularization.
DeStafeno JJ, Kim T. DeStafeno JJ, et al. Arch Ophthalmol. 2007 Jun;125(6):834-6. doi: 10.1001/archopht.125.6.834. Arch Ophthalmol. 2007. PMID: 17562998 No abstract available.
Subconjunctival bevacizumab for corneal neovascularization in herpetic stromal keratitis.
Carrasco MA. Carrasco MA. Cornea. 2008 Jul;27(6):743-5. doi: 10.1097/QAI.0b013e31815b833a. Cornea. 2008. PMID: 18580272
Bevacizumab: a new way of doing business?
Canning C, Lotery A. Canning C, et al. Eye (Lond). 2006 Sep;20(9):985-7. doi: 10.1038/sj.eye.6702501. Epub 2006 Jul 21. Eye (Lond). 2006. PMID: 16858443 Review.
Bevacizumab in the treatment of breast cancer.
Koutras AK, Fountzilas G, Makatsoris T, Peroukides S, Kalofonos HP. Koutras AK, et al. Cancer Treat Rev. 2010 Feb;36(1):75-82. doi: 10.1016/j.ctrv.2009.10.007. Epub 2009 Nov 22. Cancer Treat Rev. 2010. PMID: 19932567 Review.

See all similar articles

Cited by

circ-ZNF609: A potent circRNA in human cancers.
Qian Y, Li Y, Li R, Yang T, Jia R, Ge YZ. Qian Y, et al. J Cell Mol Med. 2021 Nov;25(22):10349-10361. doi: 10.1111/jcmm.16996. Epub 2021 Oct 26. J Cell Mol Med. 2021. PMID: 34697887 Free PMC article. Review.
Paxillin regulates vascular endothelial growth factor A-induced in vitro angiogenesis of human umbilical vein endothelial cells.
Yang WJ, Yang YN, Cao J, Man ZH, Li Y, Xing YQ. Yang WJ, et al. Mol Med Rep. 2015 Mar;11(3):1784-92. doi: 10.3892/mmr.2014.2961. Epub 2014 Nov 17. Mol Med Rep. 2015. PMID: 25405379 Free PMC article.
Corneal neovascularization during experimental fungal keratitis.
Yuan X, Wilhelmus KR. Yuan X, et al. Mol Vis. 2009 Sep 29;15:1988-96. Mol Vis. 2009. PMID: 19816603 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley